Efficacy and Safety Of Xeloda as Sequential Adjuvant Therapy After Chemotherapy in Breast Cancer
Clinical trial NCT01662128 · UNKNOWN
Trial details
- NCT number
- NCT01662128
- Sponsor
- Tianjin Medical University
- Status
- UNKNOWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-06-01
- Primary completion
- 2014-06-01
- Enrollment
- 600
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.